These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20833837)

  • 1. Inhibition of NF-κB signaling in human dendritic cells by the enteropathogenic Escherichia coli effector protein NleE.
    Vossenkämper A; Marchès O; Fairclough PD; Warnes G; Stagg AJ; Lindsay JO; Evans PC; Luong le A; Croft NM; Naik S; Frankel G; MacDonald TT
    J Immunol; 2010 Oct; 185(7):4118-27. PubMed ID: 20833837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The type III secretion effector NleE inhibits NF-kappaB activation.
    Nadler C; Baruch K; Kobi S; Mills E; Haviv G; Farago M; Alkalay I; Bartfeld S; Meyer TF; Ben-Neriah Y; Rosenshine I
    PLoS Pathog; 2010 Jan; 6(1):e1000743. PubMed ID: 20126447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65.
    Newton HJ; Pearson JS; Badea L; Kelly M; Lucas M; Holloway G; Wagstaff KM; Dunstone MA; Sloan J; Whisstock JC; Kaper JB; Robins-Browne RM; Jans DA; Frankel G; Phillips AD; Coulson BS; Hartland EL
    PLoS Pathog; 2010 May; 6(5):e1000898. PubMed ID: 20485572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NleE/OspZ family of effector proteins is required for polymorphonuclear transepithelial migration, a characteristic shared by enteropathogenic Escherichia coli and Shigella flexneri infections.
    Zurawski DV; Mumy KL; Badea L; Prentice JA; Hartland EL; McCormick BA; Maurelli AT
    Infect Immun; 2008 Jan; 76(1):369-79. PubMed ID: 17984206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial cells detect functional type III secretion system of enteropathogenic Escherichia coli through a novel NF-κB signaling pathway.
    Litvak Y; Sharon S; Hyams M; Zhang L; Kobi S; Katsowich N; Dishon S; Nussbaum G; Dong N; Shao F; Rosenshine I
    PLoS Pathog; 2017 Jul; 13(7):e1006472. PubMed ID: 28671993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The type III secretion effector NleF of enteropathogenic Escherichia coli activates NF-κB early during infection.
    Pallett MA; Berger CN; Pearson JS; Hartland EL; Frankel G
    Infect Immun; 2014 Nov; 82(11):4878-88. PubMed ID: 25183730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A type III effector protease NleC from enteropathogenic Escherichia coli targets NF-κB for degradation.
    Pearson JS; Riedmaier P; Marchès O; Frankel G; Hartland EL
    Mol Microbiol; 2011 Apr; 80(1):219-30. PubMed ID: 21306441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NleC, a type III secretion protease, compromises NF-κB activation by targeting p65/RelA.
    Yen H; Ooka T; Iguchi A; Hayashi T; Sugimoto N; Tobe T
    PLoS Pathog; 2010 Dec; 6(12):e1001231. PubMed ID: 21187904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The enteropathogenic E. coli (EPEC) Tir effector inhibits NF-κB activity by targeting TNFα receptor-associated factors.
    Ruchaud-Sparagano MH; Mühlen S; Dean P; Kenny B
    PLoS Pathog; 2011 Dec; 7(12):e1002414. PubMed ID: 22144899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a Distinct Substrate-binding Domain in the Bacterial Cysteine Methyltransferase Effectors NleE and OspZ.
    Zhang Y; Mühlen S; Oates CV; Pearson JS; Hartland EL
    J Biol Chem; 2016 Sep; 291(38):20149-62. PubMed ID: 27445336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enteropathogenic E. coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-κB activation.
    Royan SV; Jones RM; Koutsouris A; Roxas JL; Falzari K; Weflen AW; Kim A; Bellmeyer A; Turner JR; Neish AS; Rhee KJ; Viswanathan VK; Hecht GA
    Mol Microbiol; 2010 Dec; 78(5):1232-45. PubMed ID: 21091507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-κB and p38 mitogen-activated protein kinase activation.
    Sham HP; Shames SR; Croxen MA; Ma C; Chan JM; Khan MA; Wickham ME; Deng W; Finlay BB; Vallance BA
    Infect Immun; 2011 Sep; 79(9):3552-62. PubMed ID: 21746856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EspZ of enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation.
    Berger CN; Crepin VF; Baruch K; Mousnier A; Rosenshine I; Frankel G
    mBio; 2012; 3(5):. PubMed ID: 23033475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of expression, secretion and translocation of type III effectors during enteropathogenic Escherichia coli infection.
    Serapio-Palacios A; Finlay BB
    Curr Opin Microbiol; 2020 Apr; 54():67-76. PubMed ID: 32058947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The T3SS effector EspT defines a new category of invasive enteropathogenic E. coli (EPEC) which form intracellular actin pedestals.
    Bulgin R; Arbeloa A; Goulding D; Dougan G; Crepin VF; Raymond B; Frankel G
    PLoS Pathog; 2009 Dec; 5(12):e1000683. PubMed ID: 20011125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A type III effector antagonizes death receptor signalling during bacterial gut infection.
    Pearson JS; Giogha C; Ong SY; Kennedy CL; Kelly M; Robinson KS; Lung TW; Mansell A; Riedmaier P; Oates CV; Zaid A; Mühlen S; Crepin VF; Marches O; Ang CS; Williamson NA; O'Reilly LA; Bankovacki A; Nachbur U; Infusini G; Webb AI; Silke J; Strasser A; Frankel G; Hartland EL
    Nature; 2013 Sep; 501(7466):247-51. PubMed ID: 24025841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The WxxxE effector EspT triggers expression of immune mediators in an Erk/JNK and NF-κB-dependent manner.
    Raymond B; Crepin VF; Collins JW; Frankel G
    Cell Microbiol; 2011 Dec; 13(12):1881-93. PubMed ID: 21848814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring Effector-Mediated Modulation of Inflammatory Responses to Infection with Enteropathogenic and Shiga Toxin-Producing E. coli.
    Pollock GL; Giogha C; Hartland EL
    Methods Mol Biol; 2021; 2291():317-332. PubMed ID: 33704761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function.
    Gao X; Wan F; Mateo K; Callegari E; Wang D; Deng W; Puente J; Li F; Chaussee MS; Finlay BB; Lenardo MJ; Hardwidge PR
    PLoS Pathog; 2009 Dec; 5(12):e1000708. PubMed ID: 20041225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enterohaemorrhagic Escherichia coli serogroup O111 inhibits NF-(kappa)B-dependent innate responses in a manner independent of a type III secreted OspG orthologue.
    Nobe R; Nougayrède JP; Taieb F; Bardiau M; Cassart D; Navarro-Garcia F; Mainil J; Hayashi T; Oswald E
    Microbiology (Reading); 2009 Oct; 155(Pt 10):3214-3225. PubMed ID: 19628559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.